Immunotherapy

Immunotherapy includes companies using the immune system to fight disease, especially cancer and autoimmune conditions. This can include checkpoint inhibitors, immune agonists, engineered immune cells, therapeutic vaccines, and other approaches that modify immune activity.

Why watch Immunotherapy

This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.

Latest Immunotherapy news

The latest feed items from companies currently grouped under Immunotherapy.

1. 01
   2026-09-20 10:00 EST

   CUECue Biopharma Announces Positive Topline Results from CUE-221 Phase 2 Study in Chronic Spontaneous Urticaria

   Source: Cue Biopharma Inc

2. 02
   2026-09-15 20:05 EST

   TPSTTempest Secures Exclusive Option to License Clinical-Stage CD7-Targeted Lentiviral In Vivo CAR-T Platform

   Source: Tempest Therapeutics

3. 03
   2026-09-15 08:10 EST

   GNTASòphia High Tech Flight Hardware on Board VEGA-C VV30 as the European Launcher Carries Sentinel-3C and FLEX into Orbit

   Source: Genenta Science

4. 04
   2026-09-14 14:30 EST

   PDSBPDS Biotech Announces Initial Closing of up to $22.3 Million PIPE Financing and the Appointment of Dr. Patrick Soon-Shiong to Its Board of Directors

   Source: PDS Biotechnology Corporation

5. 05
   2026-09-14 11:30 EST

   BCTXData Safety Monitoring Board (DSMB) Recommends Continuing BriaCell’s Phase 3 Metastatic Breast Cancer Study

   Source: BriaCell

6. 06
   2026-09-14 11:00 EST

   LYELLyell Immunopharma To Participate in the Baird 2026 Global Healthcare Conference

   Source: Lyell Immunopharma

7. 07
   2026-09-14 11:00 EST

   IMCRImmunocore announces achievement of target enrollment in registrational TEBE-AM trial with KIMMTRAK® (tebentafusp) in previously treated advanced melanoma

   Source: Immunocore Holdings plc

8. 08
   2026-09-14 08:00 EST

   BNTXNeue Daten zu Gotistobart zeigten annähernde Verdopplung des medianen Gesamtüberlebens im Vergleich zur Standardchemotherapie bei Patientinnen und Patienten mit zuvor behandeltem Plattenepithelkarzinom der Lunge

   Source: BioNTech

9. 09
   2026-09-14 08:00 EST

   BNTXBioNTech and OncoC4 Present Updated Data Showing Gotistobart Nearly Doubled Median Overall Survival versus Standard-of-Care Chemotherapy in Previously Treated Squamous Non-Small Cell Lung Cancer Patients

   Source: BioNTech

10. 10
    2026-09-11 18:00 EST

    PHARFDA approves Pharming’s Joenja® as first treatment for children with APDS in the U.S.

    Source: Pharming Group

11. 11
    2026-09-11 12:00 EST

    TPSTTempest Therapeutics Announces Up to $7.5 Million Private Placement

    Source: Tempest Therapeutics

12. 12
    2026-09-11 12:00 EST

    IMMPImmutep Outlines Focused Development Strategy for Eftilagimod Alfa (“efti”)

    Source: Immutep Limited

13. 13
    2026-09-10 20:05 EST

    LYELLyell Immunopharma Completes Manufacturing Transfer for LYL273 and Provides Updated Timeline on Phase 1/2 Trial in Metastatic Colorectal Cancer

    Source: Lyell Immunopharma

14. 14
    2026-09-10 13:30 EST

    IMNNIMUNON Enters Cooperative Research and Development Agreement with National Cancer Institute to Advance Clinical Development of IMNN-001

    Source: Imunon

15. 15
    2026-09-10 12:05 EST

    CADLCandel Therapeutics Appoints Martine Zimmermann, PharmD, to its Board of Directors

    Source: Candel Therapeutics

16. 16
    2026-09-09 20:01 EST

    GNLXGenelux Announces Publication of a Deep and Durable Response in a Platinum-relapsed Small Cell Lung Cancer Patient Following Systemically Delivered Olvi-Vec-Primed Immunochemotherapy

    Source: Genelux

17. 17
    2026-09-09 12:30 EST

    IMNNIMUNON Announces Full Agenda and Speaker Lineup Ahead of 2026 R&D Day Highlighting IMNN-001 Clinical Progress

    Source: Imunon

18. 18
    2026-09-09 06:00 EST

    PHARPharming Group to participate in September investor conferences

    Source: Pharming Group

19. 19
    2026-09-08 12:30 EST

    TPSTTempest to Present at the H.C. Wainwright 28th Annual Global Investment Conference

    Source: Tempest Therapeutics

20. 20
    2026-09-08 12:30 EST

    PDSBPDS Biotech Announces up to $22.55 Million Financing Led by Dr. Patrick Soon-Shiong, Founder of NantWorks

    Source: PDS Biotechnology Corporation

Companies in Immunotherapy

68 companies tagged with Immunotherapy.

Frequently Asked Questions